Molecular Determinants Underlying Binding Specificities of the ABL Kinase Inhibitors: Combining Alanine Scanning of Binding Hot Spots with Network Analysis of Residue Interactions and Coevolution.

All inhibitors were subsequently docked into the binding site obtained from the receptor and conformation of the inhibitors with the lowest binding free energy was used to

cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology Endorsement of the College of

List of municipalities of Amazonas state (Brazil) and their number of detected hot spots (HS); mean annual hot spots; area; area divided by mean annual hot spot (HS density); hot

We demonstrated that the specific phosphorylation of this residue by the Hanks kinase YbdM stimulates phosphotransfer to DegU in vitro , and a phosphomimetic mutant of DegS leads to

Cellular target profiling by chemical proteomics identifies 79 protein kinases binding to dasatinib, nilotinib, bosutinib, and bafetinib in Ph+ ALL cells.. Dasatinib, nilotinib,

We also determined the critical strain rate (CSR), understood as the tangent of the inclination angle between the tangent to the crack development curve and the crack development

The identification of BCR-ABL expression as the defining leu- kemogenic event in chronic myeloid leukemia (CML) and the introduction of BCR-ABL tyrosine kinase inhibitors (TKIs)

Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center